Clinical trial

A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild…

NCT00157937 · Organon and Co, Industry · Completed

Key facts

NCT number NCT00157937
Title A Study to Compare Effectiveness of Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics (0476-329)
Official title A Randomized, Open Label, Cross-Over Study Comparing Effectiveness for the Montelukast Sodium With Comparator in Mild to Moderate Persistent Asthmatics
Lead sponsor Organon and Co, Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Asthma, Allergic Rhinitis
Intervention type Drug
Interventions MK0476, montelukast sodium/Duration of Treatment: 16 weeks, Comparator: theophylline ER/Duration of Treatment: 16 weeks
Enrollment 31
Start date Feb 1, 2003
Primary completion Jun 1, 2005
Completion Jun 1, 2005
First posted Sep 12, 2005
Last update posted Aug 15, 2024

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies